At Darst Dermatology in Charlotte, NC we are currently recruiting individual as research participants.
Atopic Dermatitis Clinical Study:
Vanda VP-VLY-686-3101- A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, EFFICACY STUDY OF THE NEUROKININ-1 RECEPTOR ANTAGONIST VLY-686 IN PATIENTS WITH ATOPIC DERMATITIS. Enrollment open
A Randomized, Double-Blind, Placebo-Controlled Efficacy Study of The Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis
Inclusion Criteria:
- Male and non-pregnant, non-lactating female patients aged 18 – 70 years (inclusive);
- Diagnosed with atopic dermatitis;
- Suffering from chronic pruritus;
- Body Mass Index (BMI) of ≥18 and ≤40 kg/m2
Exclusion Criteria:
- Chronic pruritus due to condition other than atopic dermatitis (AD);
- A positive test for drugs of abuse at the screening or evaluation visits;
- Exposure to any investigational medication in the past 60 days
For more information, visit clinicaltrials.gov
If interested in participating in a clinical trial at Darst Dermatology, email us at [email protected]